|
Apr 10
|
Axsome (AXSM) Moves 4.2% Higher: Will This Strength Last?
|
|
Mar 31
|
Emergent BioSolutions Announces Stock Repurchase Program
|
|
Mar 13
|
High Growth Tech Stocks In The US Market March 2025
|
|
Mar 13
|
Emergent signs financial investment agreement with Swiss Rockets
|
|
Mar 13
|
Emergent BioSolutions Reinforces its Commitment to Expanding Access to NARCAN® Nasal Spray by Supporting Organizations with New Opioid Overdose Preparedness Programs
|
|
Mar 12
|
Emergent BioSolutions and Rocketvax Announce Investment Agreement and Pursuit of a Strategic Relationship for Next-Generation Product Candidates
|
|
Mar 10
|
Emergent BioSolutions Announces Sale of Baltimore-Bayview Manufacturing Site to Syngene International
|
|
Feb 18
|
Emergent BioSolutions to Report Fourth Quarter and Full Year 2024 Financial Results on March 3, 2025
|
|
Dec 30
|
Why Emergent BioSolutions Stock Blasted Higher Today
|
|
Oct 15
|
Zacks.com featured highlights include Grupo Supervielle, Emergent BioSolutions and Innodata
|
|
Oct 14
|
3 Stocks Poised for Better Returns With New Analyst Coverage
|
|
Oct 11
|
Emergent BioSolutions Inc. (EBS): A Standout Among Best Performing Cheap Stocks in 2024
|
|
Oct 9
|
Emergent BioSolutions Inc (EBS) Q2 2024 Earnings Call Highlights: Navigating Challenges and ...
|
|
Oct 9
|
Emergent to donate 20,000 Narcan doses to fight opioid overdoses, CEO says
|
|
Sep 26
|
Emergent BioSolutions Announces the Execution of Contract Options Valued at $67.4 Million to Procure Additional TEMBEXA® (brincidofovir) to Support National Preparedness Efforts
|
|
Sep 25
|
Emergent BioSolutions Confirms Approximately $400 million in Orders in 2024 & 2025 to Support Smallpox and Mpox Preparedness Efforts
|
|
Sep 24
|
Emergent BioSolutions Inc.'s (NYSE:EBS) institutional investors lost 16% last week but have benefitted from longer-term gains
|
|
Sep 4
|
Milestone Pharmaceuticals Appoints Industry Veteran Joseph Papa to its Board of Directors
|
|
Sep 3
|
Emergent BioSolutions Successfully Refinances Debt & Further Strengthens Financial Profile
|
|
Aug 30
|
EBS Stock Rises on FDA Nod for ACAM2000 in Mpox Indication
|